Egfr Test-Guided Erlotinib Versus Chemotherapy For First-Line Treatment Of Advanced Non-Small Cell Lung Cancer- A Budget Impact Analysis
May 1, 2013, 00:00
10.1016/j.jval.2013.03.638
https://www.valueinhealthjournal.com/article/S1098-3015(13)00709-2/fulltext
Title :
Egfr Test-Guided Erlotinib Versus Chemotherapy For First-Line Treatment Of Advanced Non-Small Cell Lung Cancer- A Budget Impact Analysis
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(13)00709-2&doi=10.1016/j.jval.2013.03.638
First page :
A131
Section Title :
Cancer
Open access? :
No
Section Order :
188